CS156407B2 - - Google Patents

Info

Publication number
CS156407B2
CS156407B2 CS155767A CS155767A CS156407B2 CS 156407 B2 CS156407 B2 CS 156407B2 CS 155767 A CS155767 A CS 155767A CS 155767 A CS155767 A CS 155767A CS 156407 B2 CS156407 B2 CS 156407B2
Authority
CS
Czechoslovakia
Application number
CS155767A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS156407B2 publication Critical patent/CS156407B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CS155767A 1966-06-21 1967-03-02 CS156407B2 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH898666A CH469002A (de) 1966-06-21 1966-06-21 Verfahren zur Herstellung neuer Indolderivate

Publications (1)

Publication Number Publication Date
CS156407B2 true CS156407B2 (cs) 1974-07-24

Family

ID=4347068

Family Applications (1)

Application Number Title Priority Date Filing Date
CS155767A CS156407B2 (cs) 1966-06-21 1967-03-02

Country Status (7)

Country Link
AT (1) AT266822B (cs)
CH (1) CH469002A (cs)
CS (1) CS156407B2 (cs)
DK (1) DK124612B (cs)
ES (1) ES337458A1 (cs)
FI (1) FI47366C (cs)
SE (1) SE308110B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000152A1 (fr) * 1978-07-03 1980-02-07 Sandoz Ag Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation
EP0013878A1 (en) * 1979-01-18 1980-08-06 Sandoz Ag 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Also Published As

Publication number Publication date
FI47366C (fi) 1973-11-12
FI47366B (cs) 1973-07-31
ES337458A1 (es) 1968-03-01
AT266822B (de) 1968-12-10
CH469002A (de) 1969-02-28
SE308110B (cs) 1969-02-03
DK124612B (da) 1972-11-06

Similar Documents

Publication Publication Date Title
AU5917865A (cs)
AU428063B2 (cs)
AU424443B2 (cs)
AU414526B2 (cs)
AU433222B2 (cs)
AU421822B2 (cs)
AU417216B2 (cs)
AU415165B1 (cs)
AU1144366A (cs)
AU612166A (cs)
AU6703465A (cs)
AU5895065A (cs)
AU1111066A (cs)
AU218666A (cs)
BE284991A (cs)
BE597652A (cs)
AU433620A (cs)
AU415780B2 (cs)
AU407778B2 (cs)
AU411645B2 (cs)
BE693488A (cs)
BE690705A (cs)
AU6852465A (cs)
AU855865A (cs)
AU92366A (cs)